Medically reviewed by Maggie Ford, FNP, Aqua Vitae Greenville
Your lab results land in the patient portal, and you see two testosterone numbers instead of one. One sits comfortably in range, while the other carries a small red flag. If you have been dealing with low desire or stubborn fatigue, that mix of results can feel especially confusing.
Free and total testosterone measure the same hormone in different ways, and each tells your provider something the other cannot. Once you see how they fit together, your report becomes much easier to read. Always talk with a qualified provider before changing your care.
Free and Total Testosterone: Two Views of One Hormone
Testosterone does not travel through your blood on its own. Most of it rides on proteins, which is why labs often report it in more than one way. Knowing what each number captures is the first step toward reading your results.
Total Testosterone Counts Everything
Total testosterone measures all of the testosterone in your blood, whether it is attached to a protein or not. In women, the ovaries and adrenal glands produce this hormone, which supports sex drive, bone strength, and mood. Total testosterone is also the form labs can measure most accurately. A global consensus on testosterone for women names it the main marker to track.
Free Testosterone Is the Unbound Share
Most testosterone is attached to sex hormone-binding globulin (SHBG) or to albumin, a common blood protein. The small amount left unattached is called free testosterone. Many labs estimate this number with a formula that uses your total testosterone, SHBG, and albumin. Free testosterone can add helpful detail when your total level looks normal, but your symptoms suggest otherwise.
Why Free and Total Testosterone Results Can Disagree
It is common for one testosterone number to look normal while the other looks high or low. That gap usually comes down to SHBG and to life changes that affect hormone production. At Aqua Vitae, we review this first when results seem to clash.
SHBG and Everyday Factors Shift the Balance
When SHBG rises, it holds on to more testosterone, so your free level can drop while your total stays steady. A study of women over 65 linked several everyday factors to testosterone levels:
- Women taking oral estrogen had total and free testosterone about 47 percent lower than women who never used it.
- Women with obesity had about 47 percent higher total testosterone and 20 percent higher free testosterone.
- Women who had both ovaries removed had lower total and free testosterone.
- Women using corticosteroid medicines had much lower total testosterone than nonusers.
That’s why we ask about every medication and past surgery before we interpret your numbers.
Age Shapes Levels More Than Menopause
Many women expect testosterone to crash the moment their periods stop, but the real pattern is more gradual. Androgen levels decline steeply in early adulthood, and natural menopause doesn’t cause a sudden extra drop. The ovaries keep making some testosterone after menopause, while surgical removal of both ovaries lowers it more noticeably.
“Women often tell me they assumed menopause wiped out their testosterone overnight. The decline usually starts years earlier and moves slowly. That is why we look at your symptoms, history, and full panel together instead of reacting to one number.”
Maggie Ford, FNP, Aqua Vitae
Reading Your Free and Total Testosterone With a Provider
Testosterone numbers matter most when matched with how you feel. A low result may not call for treatment, while a high one may need its own plan. Here is how providers tend to put the pieces together.
What Low Levels Can and Cannot Tell You
Low testosterone can show up as fading desire, low energy, or mood changes. Our guide to symptoms of low testosterone walks through them in more detail. The strongest evidence for treatment covers hypoactive sexual desire disorder, or low desire that causes distress. When desire is your main concern, our female sex drive treatment options start with a careful evaluation. Testosterone may then become one part of a bioidentical hormone replacement therapy plan, with regular lab monitoring.
Testosterone and Muscle on Weight Loss Medications
If you take a GLP-1 such as semaglutide or tirzepatide, your testosterone results may matter for more than desire and energy. Losing weight on these medications means losing some lean tissue along with fat. In a body scan study of tirzepatide and body composition, about one quarter of the weight people lost was lean mass, and nearly three out of four participants were women. Because testosterone supports lean mass, a low result is worth a closer look while you are losing weight. Our article on GLP-1s and BHRT explains how hormone balance and weight loss medications can work together.
When High Free Testosterone Points to PCOS
High androgen levels are one of the key signs of polycystic ovary syndrome, or PCOS. The international PCOS guideline supports checking total or calculated free testosterone, or the free androgen index. If you also notice acne, extra facial hair, or irregular cycles, bring a high result to your provider.
Steps for More Reliable Results
Testosterone is harder to measure in women because levels are much lower than in men. Direct testosterone tests tend to lose accuracy at these low levels. These steps help you get numbers you can trust:
- Share every medication. Birth control pills, oral estrogen, and steroid medicines can all shift your results.
- Ask about the test method. Mass spectrometry measures low testosterone levels more precisely than many standard tests.
- Check SHBG at the same time. This lets your provider estimate free testosterone and explain why two numbers disagree.
- Use the same lab for repeat tests. Consistency makes trends easier to track over time.
- Review results alongside your symptoms. A number alone rarely tells the whole story of how you feel.
Making Sense of Your Free and Total Testosterone
Free and total testosterone are two views of the same hormone, and neither tells the full story alone. Bringing them together with your history is what turns a confusing report into a clear next step.
Two Numbers, One Conversation
Your results become far more meaningful when you consider SHBG, your medications, and your symptoms. A single flagged number is simply a reason to talk with someone who can see your whole picture. Our comprehensive lab testing pairs a full hormone panel with time to review every result.
Getting Answers at Aqua Vitae
If your results have left you with more questions than answers, we would love to help. Schedule a consultation with Aqua Vitae, and our team will review your labs and listen to what you are feeling. Together, we will build a plan that fits your body and your goals.
Clinical Sources
- Davis SR, Baber R, Panay N, et al. (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism, 104(10). DOI: 10.1210/jc.2019-01603. PMID: 31498871. https://pmc.ncbi.nlm.nih.gov/articles/PMC6821450/
- Cappola AR, Ratcliffe SJ, Bhasin S, et al. (2007). Determinants of Serum Total and Free Testosterone Levels in Women Over the Age of 65 Years. Journal of Clinical Endocrinology & Metabolism, 92(2), 509–516. DOI: 10.1210/jc.2006-1399. https://academiccommons.columbia.edu/doi/10.7916/D8222T3C
- Davison SL, Bell R, Donath S, Montalto JG, Davis SR. (2005). Androgen Levels in Adult Females: Changes With Age, Menopause, and Oophorectomy. Journal of Clinical Endocrinology & Metabolism, 90(7), 3847–3853. DOI: 10.1210/jc.2005-0212. PMID: 15827095. https://pubmed.ncbi.nlm.nih.gov/15827095/
- Look M, Dunn JP, Kushner RF, et al. (2025). Body Composition Changes During Weight Reduction With Tirzepatide in the SURMOUNT-1 Study of Adults With Obesity or Overweight. Diabetes, Obesity and Metabolism, 27, 2720. DOI: 10.1111/dom.16275. PMID: 39996356. https://pmc.ncbi.nlm.nih.gov/articles/PMC11965027/
- Huang G, Basaria S, Travison TG, et al. (2014). Testosterone Dose-Response Relationships in Hysterectomized Women With or Without Oophorectomy. Menopause, 21(6), 612–623. DOI: 10.1097/GME.0000000000000093. PMID: 24281237. https://pmc.ncbi.nlm.nih.gov/articles/PMC4701202/
- Teede HJ, Tay CT, Laven JJE, et al. (2023). Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. European Journal of Endocrinology, 189(2), G43–G64. DOI: 10.1093/ejendo/lvad096. PMID: 37580861. https://pubmed.ncbi.nlm.nih.gov/37580861/
- Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. (2007). Utility, Limitations, and Pitfalls in Measuring Testosterone: An Endocrine Society Position Statement. Journal of Clinical Endocrinology & Metabolism, 92(2), 405–413. DOI: 10.1210/jc.2006-1864. PMID: 17090633. https://pubmed.ncbi.nlm.nih.gov/17090633/